Alzheimer Disease and Oxidative Stress.

Perry G, Cash AD, Smith MA. · 2002

Read Alzheimer Disease and Oxidative Stress. by Perry G, Cash AD, Smith MA. (2002) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc161361.txt.

Introduction

Oxidative stress may start Alzheimer's long before plaques appear. Perry, Cash, and Smith reviewed that case in 2002. Cell changes tied to oxidation, damage by reactive oxygen, precede the disease's hallmark tangles and plaques.

The initial source of the stress stays unclear. Redox-active metals, iron and copper, likely feed the process, since they can spawn damaging oxygen species. Perry argues that pinning down this early chemistry could open new treatments. Most Alzheimer therapies of the time chased late damage; this line points upstream, to the spark itself. Their focus on metals points to iron and copper handling as a testable lead.

Catalog record

CREATORPerry G, Cash AD, Smith MA.
YEAR2002
COLLECTIONPAPERS
FORMATTXT
FILE SIZE19 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC161361

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Alzheimer Disease and Oxidative Stress By George Perry, Adam D Cash, Mark A Smith Published in: Journal of Biomedicine and Biotechnology DOI: 10.1155/S1110724302203010 ABSTRACT Abstract Research in Alzheimer disease has recently demonstrated compelling evidence on the importance of oxidative processes in its pathogenesis. Cellular changes show that oxidative stress is an event that precedes the appearance of the hallmark pathologies of the disease, neurofibrillary tangles, and senile plaques. While it is still unclear what the initial source of the oxidative stress is in Alzheimer disease, it is likely that the process is highly dependent on redox-active transition metals such as iron and copper. Further investigation into the role that oxidative stress mechanisms seem to play in the pathogenesis of Alzheimer disease may lead to novel clinical interventions. INTRODUCTION Much of the research performed on Alzheimer disease (AD) over the past decade has focused on oxidative stress mechanisms and its importance in disease pathogenesis. Multiple lines of evidence have implicated oxidative stress and free radical damage to the pathogenesis and possible etiology of AD. The net effect of oxygen radicals is damage. Such damage found in AD includes advanced glycation end products [1], nitration [2], lipid peroxidation adduction products [3, 4] as well as carbonyl-modified neurofilament protein and free carbonyls [5, 6]. Importantly, this damage involves all neurons vulnerable to death in AD, not just those containing neurofibrillary tangles. In fact, the spatio-temporal distribution of specific types of damage elegantly reflects the biology and chemistry of each modification. The cytopathological significance of oxidative damage is seen by the up-regulation of antioxidant enzymes. Heme oxygenase-1 (HO-1) is among the most sensitive and selective indicators of the cellular oxidative stress response and, in AD, we demonstrated that both HO-1 protein and its mRNA are increased in brains of AD patients [7, 8]. In later studies, we demonstrated that increased HO-1 expression co-localizes with the altered form of tau (τ) [9]. OXIDATIVE STRESS AND NFT MODIFICATION There is much substantive evidence for progressive oxidative modification of proteins as a consequence of aging. However, the most crucial aspects of the cellular oxidative damage in AD pathogenesis appear to be the cytoskeletal modifications in neurons susceptible to AD, which in turn play a key role in the irreversible cellular dysfunction that ultimately leads to neuronal death [10]. The most obvious of these cytoskeletal abnormalities are the NFT, which are arguably the most important aspect of the degenerating phenotype in AD-affected neurons. These inclusions largely consist of modified medium and high molecular weight neurofilaments (NFM and NFH, respectively) as well as the microtubule-stabilizing protein τ. In NFT, these two families of protein have an abnormally high level of phosphorylation, which may be explained by their conserved kinase consensus sequences [11]. In addition to hyperphosphorylation, proteins in both NFT and senile plaques have been shown to be modified by the addition of advanced glycation endproducts (AGE) [1] and hydroxynonenal [4]. Some of the antibodies used to detect NFT specifically recognize oxidation-dependent epitopes. We have demonstrated that two antibodies to NFT recognize carbonyl-modified epitopes of high molecular weight neurofilaments (NFH) [6]. Although both of these antibodies recognized neurofilaments of the axon in aldehyde-fixed sections, they demonstrated no reactivity in immunoblots with normal axonal protein prepared from tissue unexposed to fixatives. In contrast, if these immunoblots were carbonyl-modified, both antibodies recognized NFH. Significantly, in samples from AD brains, the antibodies recognized NFT epitopes in both tissue sections and NFT-derived NFH in immunoblots without need of carbonyl modification. Sporadic lesion-related immunoreactivity was seen in control patients. Furthermore, carbonyl-modified NFTs could be isolated from homogenates of AD brain tissue but not from control tissue. Taken together, these results suggest that oxidized NFH is a prominent antigen in NFT [6]. The oxidative conversion of protein side-chains to reactive carbonyl or acylating moieties, or adduction of bifunctional sugar- or lipid-derived products can result in abnormal protein cross-linking. Both neurofilaments and τ can form noncovalent aggregates in the absence of oxidation. However, they have a limited lifetime, and the protein-derived reactive moieties will preferentially react with solvent or other molecules if no suitably reactive and/or positioned group is nearby. We hypothesize that the pathogenic role of oxidative stress, involving direct oxidation and/or modification by oxidation, may be primarily in the covalent “cementing” of reversible associations normally reflecting simple noncovalent affinities. It has been found that many proteins associated with NFT are apparently covalently cross-linked to the filaments since they cannot be removed by denaturants. This is consistent with other studies, which show that oxidative covalent cross-linking of proteins occur predominantly when the proteins are preassociated. The in vitro enzymatic cross-linking of tau could be produced only when the protein substrates were properly associated. Since oxidation-based cross-linking reduces susceptibility to proteolytic degradation by providing nonpeptide bonds [12], covalent cross-linking may in fact represent a neurotoxic event by inhibiting turnover. Simultaneously, several oxidative modifications may generate chemical species, which themselves support further oxidative stress through “redox cycling” or transition metal sequestration. HOW OXIDATIVE DAMAGE COMPARES TEMPORALLY TO LESIONS OF ALZHEIMER DISEASE Closer examination of the spatio-temporal relationship between the presence of oxidative modification and the hallmark AD lesions reveals an apparent paradox. It has been found that while stable glycation products are predominantly associated with NFT and amyloid-β (Aβ) deposits [1], reversible or rapidly degraded adduction products are primarily in the cytoplasm of vulnerable neurons. This data means that oxidative damage is not restricted to long-lived lesions. In fact, when damage to short-lived molecules is examined, the damage is restricted to cytosolic compartments with NFT and Aβ being inversely correlated. To address where reactive oxygen species are produced, we focused our efforts to finding a marker that results from primary attack, rather than more complex secondary reactions, and which involves damage to a cell constituent with a short half-life. Proteins fail in the latter aspect of these criteria because cross-link modifications slow their turnover. Therefore, modifications associated with cross-linking of proteins, while useful to assess history, may reveal less of the current state. However, 8-hydroxyguanosine (8OHG), a nucleic acid modification predominantly derived from hydroxide (•OH) attack of guanidine, is amplified in cytoplasmic RNA in vulnerable neuronal populations [13]. Notably, cases of AD with the most extensive Aβ deposits show the lowest 8OHG levels. These findings seem markedly contradictory if we consider Aβ to be the toxic agent in AD, which is likewise proposed to be a major source of oxidative free radicals [14]. However, neurons containing NFT also have extremely low levels of 8OHG (ie, current oxidative stress status) despite an obvious history of oxidative damage (ie, advanced glycation endproducts or lipid peroxidation). This suggests that both Aβ and NFT may serve an antioxidant function, and thus be cellular compensations for increased oxidative stress. The hypothesis that Aβ plays an antioxidant function is supported by a study of Down syndrome patients, a disease where Aβ deposits begin in the late teens and in which oxidative stress has been implicated [15]. MITOCHONDRIAL ABNORMALITIES: THE MAIN SOURCE OF OXIDATIVE IMBALANCE? Mitochondria are a potential major source of oxidative radicals and oxidative precursors, in the form of O2− and H2O2, respectively, since their production is linked to metabolism. In early studies, we found increases in mitochondrial DNA in the cell

Read the complete text